Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 991.00K | £ 970.00K | £ 528.00K | £ 928.00K | £ 177.00K |
Total Assets | £ 91.61M | £ 89.33M | £ 80.20M | £ 80.26M | £ 74.85M |
Total Debt | £ 27.96M | £ 25.38M | £ 25.43M | £ 27.80M | £ 24.65M |
Net Debt | £ 26.97M | £ 24.41M | £ 24.91M | £ 26.87M | £ 24.47M |
Total Liabilities | £ 35.18M | £ 33.12M | £ 29.36M | £ 33.11M | £ 28.71M |
Stockholders Equity | £ 56.43M | £ 56.21M | £ 50.84M | £ 47.15M | £ 46.14M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |